Android app Apple app link

Intellia Therapeutics, Inc. (NTLA) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$13.15

$0.75 (-5.4%)
Last update: 04:04 PM EST
Day's range
$12.94
Day's range
$13.95

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
01/27/2026 Robert W. Baird Jack Allen $7.00 $14.40   -51.37%
10/30/2025 Wedbush David Nierengarten $9.00 $12.49   -27.94%
10/30/2025 H.C. Wainwright Mitchell Kapoor $18.00 $13.12   37.2%
10/30/2025 Robert W. Baird Jack Allen $9.00 $13.12   -31.4%
10/28/2025 Barclays Gena Wang $24.00 $14.79   62.27%
10/28/2025 Tudor Pickering William Pickering $14.50 $14.79   -1.96%
10/28/2025 RBC Capital Luca Issi $14.00 $14.79   -5.34%
10/27/2025 H.C. Wainwright Mitchell Kapoor $25.00 $25.60   -2.34%
10/06/2025 JMP Securities Silvan Tuerkcan $33.00 $19.96   65.33%
08/13/2025 Guggenheim Debjit Chattopadhyay $14.00 $11.25   24.44%
11/11/2024 Oppenheimer Jay Olson $60.00 $17.16   249.65%
10/24/2024 Robert W. Baird Jack Allen $18.00 $15.85   13.56%
08/09/2024 RBC Capital Luca Issi $54.00 $22.38   141.29%
06/24/2024 Stifel Nicolaus Dae Gon Ha $80.00 $25.22   217.21%
06/24/2024 Robert W. Baird Jack Allen $24.00 $26.00   -7.67%
05/10/2024 BMO Capital Kostas Biliouris $70.00 $24.84   181.8%
06/16/2022 BMO Capital Kostas Biliouris $54.00 $41.44   30.31%
05/08/2022 Raymond James Steven Seedhouse $105.00 $47.57   120.73%
02/23/2022 RBC Capital Luca Issi $150.00 $87.46   71.51%
02/17/2022 William Blair Raju Prasad $144.00 $86.52   66.44%
02/14/2022 Truist Financial Joon Lee $160.00 $98.52   62.4%
02/02/2022 Piper Sandler Swapnil Malekar $171.00 $94.53   80.89%
02/02/2022 Wedbush David Nierengarten $108.00 $94.53   14.25%
11/15/2021 Roth Capital Anthony Butler $180.00 $137.51   30.9%
08/05/2021 Goldman Sachs Salveen Richter $252.00 $167.31   50.62%
08/05/2021 Raymond James Steven Seedhouse $181.00 $167.31   8.18%
08/04/2021 Barclays Gena Wang $207.00 $165.16   25.33%
06/21/2021 Jefferies Maury Raycroft $109.00 $78.91   38.13%

Intellia Therapeutics, Inc. FAQ's

Intellia Therapeutics, Inc. has been rated by research analysts at KeyBanc, Robert W. Baird, Evercore ISI, Truist Financial, Oppenheimer, Wedbush in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.